2017
DOI: 10.3389/fimmu.2017.00977
|View full text |Cite
|
Sign up to set email alerts
|

Single-Domain Antibodies As Versatile Affinity Reagents for Analytical and Diagnostic Applications

Abstract: With just three CDRs in their variable domains, the antigen-binding site of camelid heavy-chain-only antibodies (HcAbs) has a more limited structural diversity than that of conventional antibodies. Even so, this does not seem to limit their specificity and high affinity as HcAbs against a broad range of structurally diverse antigens have been reported. The recombinant form of their variable domain [nanobody (Nb)] has outstanding properties that make Nbs, not just an alternative option to conventional antibodie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
130
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 142 publications
(137 citation statements)
references
References 108 publications
0
130
0
1
Order By: Relevance
“…In addition, sdAb is easily selected and cloned by selection systems such as phage, yeast, or ribosomal display (Harmsen and De Haard 2007;Muyldermans et al 2009). These attributes make sdAbs suitable for many medical, biotechnological, diagnostic, and therapeutic applications (Arbabi-Ghahroudi 2017; Bannas et al 2017;Beghein and Gettemans 2017;Gonzalez-Sapienza et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…In addition, sdAb is easily selected and cloned by selection systems such as phage, yeast, or ribosomal display (Harmsen and De Haard 2007;Muyldermans et al 2009). These attributes make sdAbs suitable for many medical, biotechnological, diagnostic, and therapeutic applications (Arbabi-Ghahroudi 2017; Bannas et al 2017;Beghein and Gettemans 2017;Gonzalez-Sapienza et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Over the decades, sdAbs, more frequently referred to be as nanobodies, has been described as a credible next-generation antibody-derived biologics with significant as advances over conventional antibodies [30]. e sdAbs produced by Camelidae that has only one variable region (heavy chain), with a reduced size, and show greater stability under a range of conditions for medical and technological applications [12,31]. In contrast to McAb, lymphocytes from the PBMC pool of immunized camels should be a good source of Agbinding sdAb fragments for the construction of a large immune library.…”
Section: Discussionmentioning
confidence: 99%
“…The antigen binding domain of Ig-NARs or HCAbs involves a single domain only, referred to as V-NAR when derived from Ig-NARs and VHHs (nanobodies) when derived from HCAbs. The nanobodies have proven to be powerful tools in diagnostics due to their unique characteristics [135]. In particular, the recombinant expression of nanobodies in microbial systems and straightforward purification using His-tag by immobilised metal affinity chromatography makes their purification easy and very cheap.…”
Section: Prospects Of Nanobodies For Use In Immunoassaysmentioning
confidence: 99%